Cresco Labs Inc.
CRLBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -6% | -8.5% | 2.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.3% | 42.8% | 48.3% | 49.5% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 15% | -1.9% | -1.2% | -19.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -10.3% | -22.8% | -25.2% | -38.9% |
| EPS Diluted | -0.22 | -0.54 | -0.71 | -1.22 |
| % Growth | 59.3% | 23.9% | 41.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |